STAT October 17, 2024
Mario Aguilar

Blue Note’s failure holds lessons for other digital therapeutics startups

The bad news didn’t come all at once for Blue Note Therapeutics, but a final denial from the Food and Drug Administration in January proved to be the final blow.

In late 2023, after a rejection from the agency earlier in the year, Blue Note had made a last...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Technology
Flattening the curve: How smartwatches could help stop a pandemic before it even begins
Technology and Leadership Will Merge At New Chief Digital Executive Exchange
Unlocking the power of sensor data in type 2 diabetes care
AI Agents: The Transformative Architects Of The Digital Age
Healthcare’s Hottest Trends: AI, Layoffs, and a Measles Comeback Tour

Share This Article